Potential covalent drugs targeting the main protease of the SARS-CoV-2 coronavirus
Motivation: Since December 2019, the newly identified coronavirus SARS-CoV-2 has caused a massive health crisis worldwide and resulted in over 70,000 COVID-19 infections so far. Clinical drugs targeting SARS-CoV-2 are urgently needed to decrease the high fatality rate of confirmed COVID-19 patients....
| Autores principales: | , , |
|---|---|
| Formato: | Other publications |
| Publicado: |
2020-04-01
|
| Materias: | |
| Acceso en línea: | https://doi.org/10.1093/bioinformatics/btaa224 https://hdl.handle.net/20.500.12663/956 |